To that end he is changing the structure of the research labs, from monoliths to smaller units that are either entrepreneurial (racing to develop a drug) or exploratory (looking for new biology to study).
Peter Kim, Merck's head of research and development, said on the company's conference call that the study for migraine prevention was "exploratory" and used a different dosing schedule than other telcagepant trials.